XSpray Pharma AB (publ)

Financial Performance

• Loss before income tax for the first quarter amounted to SEK -35,380 thousand (compared to SEK -42,321 thousand in the year-earlier period).
• Loss for the period totaled SEK -35,362 thousand (SEK -42,291 thousand).
• Earnings per share before and after dilution were SEK -0.85 (SEK -1.14).
• Cash flow from operating activities was SEK -30,676…